Ridazolol
Code | Size | Price |
---|
TAR-T26081-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26081-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26081-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Ridazolol is a vasodilating and cardioselective beta adrenergic blocker.
CAS:
83395-21-5
Formula:
C15H18Cl2N4O3
Molecular Weight:
373.23
Purity:
0.98
SMILES:
OC(CNCCNc1cn[nH]c(=O)c1Cl)COc1ccccc1Cl
References
1. Unger P, Berkenboom G, Fontaine J. Study of ridazolol on isolated canine and human coronary arteries. Cardiovasc Drugs Ther. 1989 Jun;3(3):459-64. PubMed PMID: 2577285.
2. Fach WA, Starke E, Becker HJ. [Duration of the effect and dose-response relationship of ridazolol in patients with coronary heart disease]. Z Kardiol. 1992 Jun;81(6):320-5. German. PubMed PMID: 1353933.
3. Haerer W, Henze E, Stauch M. [The effect of a combination of ridazolol and molsidomine on hemodynamics and left ventricular function in dilated cardiomyopathy]. Arzneimittelforschung. 1989 Jun;39(6):714-6. German. PubMed PMID: 2570582.
4. Rommel T, Demisch L. Influence of chronic beta-adrenoreceptor blocker treatment on melatonin secretion and sleep quality in patients with essential hypertension. J Neural Transm Gen Sect. 1994;95(1):39-48. PubMed PMID: 7857585.